View Older Stories View More Recent Stories

Dec 7, 2020 08:05AM Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin
Dec 7, 2020 08:05AM Aeterna Zentaris Announces European Licensing Agreement with Consilient Health Ltd. for Commercialization of Macimorelin
Nov 16, 2020 08:08AM Aeterna Zentaris (AEZS) Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
Nov 16, 2020 08:05AM Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
Nov 16, 2020 08:05AM Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
Nov 6, 2020 08:35AM Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
Nov 6, 2020 08:35AM Aeterna Zentaris Reports Third Quarter 2020 Financial Results and Provides Business Update
Sep 16, 2020 08:05AM Aeterna Zentaris (AEZS) Provides Corporate Update
Sep 16, 2020 08:05AM Aeterna Zentaris Provides Corporate Update
Sep 16, 2020 08:05AM Aeterna Zentaris Provides Corporate Update
Sep 9, 2020 08:00AM Aeterna Zentaris to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Sep 9, 2020 08:00AM Aeterna Zentaris to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Sep 8, 2020 08:05AM Aeterna Zentaris Announced Presentation of Positive Results from First Pediatric Study of Macimorelin at the 22nd European Congress of Endocrinology
Sep 8, 2020 08:05AM Aeterna Zentaris Announced Presentation of Positive Results from First Pediatric Study of Macimorelin at the 22nd European Congress of Endocrinology
Aug 6, 2020 08:35AM Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 6, 2020 08:35AM Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update
Aug 5, 2020 05:45PM Aeterna Zentaris Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market
Aug 3, 2020 09:01AM Aeterna Zentaris (AEZS) announces $7M direct offering of common stock, warrants
Aug 3, 2020 09:00AM AETERNA ZENTARIS ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET
Aug 3, 2020 09:00AM AETERNA ZENTARIS ANNOUNCES $7.0 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET
Jul 31, 2020 07:35AM Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications
Jul 31, 2020 07:35AM Aeterna Zentaris Announces Continued Expansion of Intellectual Property Portfolio for Macimorelin with Additional Patent Applications
Jul 30, 2020 07:35AM AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY
Jul 30, 2020 07:35AM AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY
Jul 29, 2020 07:24AM Aeterna Zentaris (AEZS) Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
Jul 29, 2020 07:05AM Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
Jul 29, 2020 07:05AM Aeterna Zentaris Receives Nasdaq Notification Regarding Minimum Bid Price Compliance; No Immediate Impact on Listing
Jul 7, 2020 04:05PM AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING
Jul 7, 2020 04:05PM AETERNA ZENTARIS ANNOUNCES CLOSING OF $12 MILLION PUBLIC OFFERING
Jul 2, 2020 05:57AM Aeterna Zentaris (AEZS) Prices 26.67M Unit Offering at $0.45/Unit
Jul 1, 2020 10:10PM AETERNA ZENTARIS ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERING
Jul 1, 2020 10:10PM AETERNA ZENTARIS ANNOUNCES PRICING OF $12 MILLION PUBLIC OFFERING
Jun 25, 2020 08:00AM AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY
Jun 25, 2020 08:00AM AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY
Jun 8, 2020 08:12AM Aeterna Zentaris (AEZS) Regains Compliance With Nasdaq Minimum Bid Price Requirement
Jun 8, 2020 08:05AM Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement
Jun 8, 2020 08:05AM Aeterna Zentaris Regains Compliance With Nasdaq Minimum Bid Price Requirement
Jun 4, 2020 04:21PM Aeterna Zentaris (AEZS) Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements
Jun 4, 2020 04:05PM Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements
Jun 4, 2020 04:05PM Aeterna Zentaris Receives Extension From Nasdaq to Satisfy Continuing Listing Requirements
May 15, 2020 04:45PM Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders
May 15, 2020 04:45PM Aeterna Zentaris Announces Results of 2020 Annual Meeting of Shareholders
May 8, 2020 09:00AM Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders
May 8, 2020 09:00AM Aeterna Zentaris Announces Virtual 2020 Annual Meeting of Shareholders
May 6, 2020 08:05AM Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results
May 6, 2020 08:05AM Aeterna Zentaris Reports First Quarter 2020 Financial and Operating Results
Apr 15, 2020 04:06PM Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing
Apr 15, 2020 04:06PM Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing
Apr 15, 2020 09:15AM Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit
Apr 15, 2020 09:15AM Aeterna Zentaris to Present at the April 2020 Virtual Investor Summit
View More Recent Stories View Older Stories